GBCS
Selectis Health, Inc.Company with tickers: GBCS
CIK
727346
CUSIP
816291108
Shares Outstanding
3,067,059
Website
https://www.selectis.com
Investor Relations
https://ir.selectis.com/
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Krystal Eckhart | Interim CFO | Appointed | 2026-05-20 |
| Krystal Eckhart | Interim CEO | Appointed | 2026-05-20 |
| Adam Desmond | member of the Board of Directors | Resigned | 2026-05-20 |
| Adam Desmond | CFO | Resigned | 2026-05-20 |
| Adam Desmond | CEO | Resigned | 2026-05-20 |